N-RAS, H-RAS, AND K-RAS - A DIFFERENCE IN TRANSFORMING POTENTIAL

被引:0
|
作者
MAHER, J
BAKER, DA
DIBB, NJ
ROBERTS, IAG
机构
[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HAEMATOL,LONDON W12 0HS,ENGLAND
[2] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT OBSTET & GYNECOL,LONDON W12 0HS,ENGLAND
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A295 / A295
页数:1
相关论文
共 50 条
  • [1] H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers
    Przybojewska, B
    Jagiello, A
    Jalmuzna, P
    CANCER GENETICS AND CYTOGENETICS, 2000, 121 (01) : 73 - 77
  • [2] EVIDENCE FOR CELL-SPECIFIC DIFFERENCES IN TRANSFORMATION BY N-RAS, H-RAS AND K-RAS
    MAHER, J
    BAKER, DA
    MANNING, M
    DIBB, NJ
    ROBERTS, IAG
    ONCOGENE, 1995, 11 (08) : 1639 - 1647
  • [3] ANALYSIS OF H-RAS, K-RAS AND N-RAS GENES FOR EXPRESSION, MUTATION AND AMPLIFICATION IN LARYNGEAL TUMORS
    KIARIS, H
    SPANDIDOS, DA
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (01) : 75 - 80
  • [4] Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms
    Couce, ME
    Bautista, D
    Costa, J
    Carter, D
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1999, 8 (02) : 71 - 79
  • [5] Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients
    Malgorzata Banys-Paluchowski
    Karin Milde-Langosch
    Tanja Fehm
    Isabell Witzel
    Leticia Oliveira-Ferrer
    Barbara Schmalfeldt
    Volkmar Müller
    Breast Cancer Research and Treatment, 2020, 179 : 403 - 414
  • [6] Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors
    Vageli, D
    Kiaris, H
    Delakas, D
    Anezinis, P
    Cranidis, A
    Spandidos, DA
    CANCER LETTERS, 1996, 107 (02) : 241 - 247
  • [7] The K-Ras, N-Ras, and H-Ras Isoforms: Unique Conformational Preferences and Implications for Targeting Oncogenic Mutants
    Parker, Jillian A.
    Mattos, Carla
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (08):
  • [8] Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients
    Banys-Paluchowski, Malgorzata
    Milde-Langosch, Karin
    Fehm, Tanja
    Witzel, Isabell
    Oliveira-Ferrer, Leticia
    Schmalfeldt, Barbara
    Mueller, Volkmar
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (02) : 403 - 414
  • [9] IMMUNOHISTOCHEMICAL DETECTION OF THE H-RAS, K-RAS, AND N-RAS ONCOGENES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    MCDONALD, JS
    JONES, H
    PAVELIC, ZP
    PAVELIC, LJ
    STAMBROOK, PJ
    GLUCKMAN, JL
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1994, 23 (08) : 342 - 346
  • [10] INFREQUENT INVOLVEMENT OF MUTATIONS ON NEUROFIBROMATOSIS TYPE-1, H-RAS, K-RAS AND N-RAS IN UROTHELIAL TUMORS
    UCHIDA, T
    WADA, C
    ISHIDA, H
    EGAWA, S
    AO, T
    YOKOYAMA, E
    KOSHIBA, K
    UROLOGIA INTERNATIONALIS, 1995, 55 (02) : 63 - 67